Cilostazol 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±2.0 mmHg at 25℃ |
| Water Solubility | Insoluble |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.676 |
| B pt. | 664.7℃ at 760 mmHg |
| M pt. | 160℃ |
| Density | 1.34 g/cm3 |
Safety Information
| Symbol | |
| HS Code | 2933990090 |
| Flash point | 355.8℃ |
| Storage Temp. | Store at room temperature. |
| Storage Class | 3 |
| Packaging | Poly Bottle |
| UN Number | 1992 |
Description
Recommended products
1-Bromoanthracene 97.0%(GC)
Application
Cilostazol has been used to reduce MadinDarby cell line (MDCK) proliferation through c-Myc down-regulation in the in vitro assessment of toxin delivery in T84 intestinal epithelial cells to induce adenosine triphosphate (ATP) release in white adipocytes.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Cilostazol prevents platelet aggregation and has vasodilatory properties. It is used to treat chronic arterial disease and intermittent claudication.Cilostazol has antiproliferative effects and improves the properties of prostacyclin.It regulates cell proliferation stimulates cyclic adenosine monophosphate (cAMP) level and induces cyclic AMP-dependent protein kinase
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |